Use of 5-fluorocytosine in systemic candidiasis in infancy

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Three cases of systemic candidiasis were successfully treated with 5-fluorocytosine (5-FC), an antifungal agent. The fungaemia developed during continuous intravenous alimentation for intestinal malabsorption. The diagnosis was confirmed by repeated positive cultures from blood, urine, and faeces. The fungus was also grown from cultures of intravenous solutions and catheters. The clinical features varied and included unexplained fever, oedema, stupor, tachypnoea, convulsions, hepatosplenomegaly, and congestive heart failure. The clinical symptoms receded rapidly and the cultures became negative after oral or intravenous treatment with 5-FC.

Cite

CITATION STYLE

APA

Isacson, M., Noah, Z., Faber, J., Herishano, Y., & Gottfried, L. (1972). Use of 5-fluorocytosine in systemic candidiasis in infancy. Archives of Disease in Childhood. BMJ Publishing Group. https://doi.org/10.1136/adc.47.256.954

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free